Cargando…

Antibodies as Snakebite Antivenoms: Past and Future

Snakebite envenomation is considered a neglected tropical disease, affecting tens of thousands of people each year. The recommended treatment is the use of antivenom, which is composed of immunoglobulins or immunoglobulin fragments obtained from the plasma of animals hyperimmunized with one (monospe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dias da Silva, Wilmar, De Andrade, Sonia A., Megale, Ângela Alice Amadeu, De Souza, Daniel Alexandre, Sant’Anna, Osvaldo Augusto, Magnoli, Fábio Carlos, Guidolin, Felipe Raimondi, Godoi, Kemily Stephanie, Saladini, Lucas Yuri, Spencer, Patrick Jack, Portaro, Fernanda Calheta Vieira
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503307/ https://www.ncbi.nlm.nih.gov/pubmed/36136544 http://dx.doi.org/10.3390/toxins14090606

Ejemplares similares

Bitis arietans Snake Venom and Kn-Ba, a Snake Venom Serine Protease, Induce the Production of Inflammatory Mediators in THP-1 Macrophages
por: Megale, Ângela Alice Amadeu, et al.
Publicado: (2021)

Comparing Traditional and Toxin-Oriented Approaches towards Antivenom Production against Bitis arietans Snake Venom
por: Guidolin, Felipe Raimondi, et al.
Publicado: (2023)

Anti-Metalloproteases: Production and Characterization of Polyclonal IgG Anti-F2 Fraction Antibodies Purified from the Venom of the Snake Bitis arietans
por: de Godoi, Kemily Stephanie, et al.
Publicado: (2023)

Bitis arietans Snake Venom Induces an Inflammatory Response Which Is Partially Dependent on Lipid Mediators
por: Megale, Angela Alice Amadeu, et al.
Publicado: (2020)

Development of Equine IgG Antivenoms against Major Snake Groups in Mozambique
por: Guidolin, Felipe Raimondi, et al.
Publicado: (2016)

Diversity of Micrurus Snake Species Related to Their Venom Toxic Effects and the Prospective of Antivenom Neutralization
por: Tanaka, Gabriela D., et al.
Publicado: (2010)

Situation of snakebite, antivenom market and access to antivenoms in ASEAN countries
por: Patikorn, Chanthawat, et al.
Publicado: (2022)

Kn-Ba: a novel serine protease isolated from Bitis arietans snake venom with fibrinogenolytic and kinin-releasing activities
por: Megale, Ângela Alice Amadeu, et al.
Publicado: (2018)

Cost of Manufacturing for Recombinant Snakebite Antivenoms
por: Jenkins, Timothy Patrick, et al.
Publicado: (2020)

Antivenoms for Snakebite Envenoming: What Is in the Research Pipeline?
por: Alirol, Emilie, et al.
Publicado: (2015)

Cost-effectiveness of Antivenoms for Snakebite Envenoming in Nigeria
por: Habib, Abdulrazaq G., et al.
Publicado: (2015)

Recent Advances in Next Generation Snakebite Antivenoms
por: Knudsen, Cecilie, et al.
Publicado: (2018)

Biosynthetic Oligoclonal Antivenom (BOA) for Snakebite and Next-Generation Treatments for Snakebite Victims †
por: Kini, R. Manjunatha, et al.
Publicado: (2018)

The Need for Next-Generation Antivenom for Snakebite Envenomation in India
por: Vanuopadath, Muralidharan, et al.
Publicado: (2023)

The complementarity-determining region sequences in IgY antivenom hypervariable regions
por: da Rocha, David Gitirana, et al.
Publicado: (2017)

Effective, polyvalent, affordable antivenom needed to treat snakebite in Nepal
por: Shrestha, Bhola R, et al.
Publicado: (2017)

Effectiveness of repeated antivenom therapy for snakebite-related systemic complications
por: Park, Kyung Hoon, et al.
Publicado: (2019)

Snakebite and local envenomation by Boiruna maculata treated without antivenom
por: Terashige, Shou, et al.
Publicado: (2021)

Cost-Effectiveness of Antivenoms for Snakebite Envenoming in 16 Countries in West Africa
por: Hamza, Muhammad, et al.
Publicado: (2016)

African Adders: Partial Characterization of Snake Venoms from Three Bitis Species of Medical Importance and Their Neutralization by Experimental Equine Antivenoms
por: Paixão-Cavalcante, Danielle, et al.
Publicado: (2015)

Preclinical Evaluation of the Efficacy of Antivenoms for Snakebite Envenoming: State-of-the-Art and Challenges Ahead
por: Gutiérrez, José María, et al.
Publicado: (2017)

The Search for Natural and Synthetic Inhibitors That Would Complement Antivenoms as Therapeutics for Snakebite Envenoming
por: Gutiérrez, José María, et al.
Publicado: (2021)

Snakebite envenoming at MSF: A decade of clinical challenges and antivenom access issues
por: Potet, Julien, et al.
Publicado: (2022)

Plant-Derived Toxin Inhibitors as Potential Candidates to Complement Antivenom Treatment in Snakebite Envenomations
por: Adrião, Asenate A. X., et al.
Publicado: (2022)

Recombinant snakebite antivenoms: A cost-competitive solution to a neglected tropical disease?
por: Laustsen, Andreas H., et al.
Publicado: (2017)

Case Report: Treatment of a Severe Puff Adder Snakebite Without Antivenom Administration
por: Wakasugi, Masahiro, et al.
Publicado: (2021)

Availability, accessibility and use of antivenom for snakebite envenomation in Africa with proposed strategies to overcome the limitations
por: Dalhat, Mahmood Muazu, et al.
Publicado: (2023)

Antivenom access impacts severity of Brazilian snakebite envenoming: A geographic information system analysis
por: Isaacson, Julia Elizabeth, et al.
Publicado: (2023)

Death Adder Envenoming Causes Neurotoxicity Not Reversed by Antivenom - Australian Snakebite Project (ASP-16)
por: Johnston, Christopher I., et al.
Publicado: (2012)

Green medicine as a harmonizing tool to antivenom therapy for the clinical management of snakebite: The road ahead
por: Mukherjee, Ashis K.
Publicado: (2012)

Potential Utilization of a Polysaccharide from the Marine Algae Gayralia oxysperma, as an Antivenom for Viperidae Snakebites
por: da Silva, Ana Cláudia Rodrigues, et al.
Publicado: (2018)

Acute Severe Anaphylaxis in Nepali Patients with Neurotoxic Snakebite Envenoming Treated with the VINS Polyvalent Antivenom
por: Sharma, Sanjib Kumar, et al.
Publicado: (2019)

A painful journey to antivenom: The therapeutic itinerary of snakebite patients in the Brazilian Amazon (The QUALISnake Study)
por: Cristino, Joseir Saturnino, et al.
Publicado: (2021)

Anti-Metalloprotease P-I Single-Domain Antibodies: Tools for Next-Generation Snakebite Antivenoms
por: Silva, Marcela C. S., et al.
Publicado: (2022)

Effect of the time to antivenom administration on recovery from snakebite envenoming-related coagulopathy in French Guiana
por: Houcke, Stéphanie, et al.
Publicado: (2023)

Identifying high snakebite risk area under climate change for community education and antivenom distribution
por: Yousefi, Masoud, et al.
Publicado: (2023)

Preclinical antivenom-efficacy testing reveals potentially disturbing deficiencies of snakebite treatment capability in East Africa
por: Harrison, Robert A., et al.
Publicado: (2017)

Dose of antivenom for the treatment of snakebite with neurotoxic envenoming: Evidence from a randomised controlled trial in Nepal
por: Alirol, Emilie, et al.
Publicado: (2017)

Biogeographic venom variation in Russell’s viper (Daboia russelii) and the preclinical inefficacy of antivenom therapy in snakebite hotspots
por: Senji Laxme, R. R., et al.
Publicado: (2021)

Exploring the Utility of Recombinant Snake Venom Serine Protease Toxins as Immunogens for Generating Experimental Snakebite Antivenoms
por: Alomran, Nessrin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kda45m674sh1jv19riqe6l4f8g